Article summary
Law360, London: Counsel for AstraZeneca convinced the Court of Appeal on 31 March 2025 to review a decision to let rival Glenmark release its generic version of a billion-dollar diabetes treatment under an agreement that the company can ship supplies of the drug already packed in trucks as long as it does not move ahead with retail sales in the meantime.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial